Related references
Note: Only part of the references are listed.Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations
Yin Wang et al.
JOURNAL OF FUNCTIONAL FOODS (2023)
Hydroxypropyl-β-cyclodextrin Enhances Oral Absorption of Silymarin Nanoparticles Prepared Using PureNano™ Continuous Crystallizer
Risako Onodera et al.
PHARMACEUTICS (2022)
A review on the mechanisms of the effect of silymarin in milk thistle (Silybum marianum) on some laboratory animals
Roshanak Khazaei et al.
VETERINARY MEDICINE AND SCIENCE (2022)
Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions
Tomas Koltai et al.
JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE (2022)
Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents
Sheema Hashem et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Biosynthesis and cytotoxic effect of silymarin-functionalized selenium nanoparticles induced autophagy mediated cellular apoptosis via downregulation of PI3K/Akt/mTOR pathway in gastric cancer
Xiao-Jie Mi et al.
PHYTOMEDICINE (2022)
In vitro Dissolution Testing and Pharmacokinetic Studies of Silymarin Solid Dispersion After Oral Administration to Healthy Pigs
Ying Xu et al.
FRONTIERS IN VETERINARY SCIENCE (2022)
Mechanistic Insights into the Pharmacological Significance of Silymarin
Karan Wadhwa et al.
MOLECULES (2022)
Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy
Soosan Sadegha et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Silibinin exhibits anti- tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis
Javad Firouzi et al.
BIOIMPACTS (2022)
Treatment strategies in cervical cancer: treatment of advanced disease
Augusto Valdivia et al.
JOURNAL OF CANCER METASTASIS AND TREATMENT (2022)
Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis
Javad Firouzi et al.
BIOIMPACTS (2022)
Cancer Chemopreventive Activities of Silibinin on Colorectal Cancer through Regulation of E-Cadherin/β-Catenin Pathway
Saba Sameri et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)
HPV post-infection microenvironment and cervical cancer
Yi Yuan et al.
CANCER LETTERS (2021)
Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer
Maryam Fallah et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Potential Mechanisms of Plant-Derived Natural Products in the Treatment of Cervical Cancer
Meizhu He et al.
BIOMOLECULES (2021)
General insight into cancer: An overview of colorectal cancer (Review)
Shiekhah Mohammad Alzahrani et al.
MOLECULAR AND CLINICAL ONCOLOGY (2021)
Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis
Sung-Hyun Kim et al.
ONCOLOGY LETTERS (2021)
A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis
Tomasz Sawicki et al.
CANCERS (2021)
Gastrointestinal cancer classification and prognostication from histology using deep learning: Systematic review
Sara Kuntz et al.
EUROPEAN JOURNAL OF CANCER (2021)
Up-down regulation of HIF-1α in cancer progression
Mohsen Rashid et al.
GENE (2021)
Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer
Saba Sameri et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2021)
Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion
Lingling Si et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials
Mehdi Koushki et al.
POSTGRADUATE MEDICAL JOURNAL (2020)
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Anton Gillessen et al.
ADVANCES IN THERAPY (2020)
The effect of resveratrol supplementation on C-reactive protein (CRP) in type 2 diabetic patients: Results from a systematic review and meta-analysis of randomized controlled trials
Hossein Hosseini et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2020)
Cold Atmospheric Plasma and Silymarin Nanoemulsion Activate Autophagy in Human Melanoma Cells
Manish Adhikari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Tumor-targeted delivery of silibinin and IPI-549 synergistically inhibit breast cancer by remodeling the microenvironment
Min Jiang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis
Ying Liu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
Mehdi Sharifi-Rad et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Implications of HIF-1 alpha in the tumorigenesis and progression of pancreatic cancer
Xiao Jin et al.
CANCER CELL INTERNATIONAL (2020)
Cervical cancer in low and middle-income countries
Rodney Hull et al.
ONCOLOGY LETTERS (2020)
Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
Rasool Haddadi et al.
PHYTOMEDICINE (2020)
A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab
Tsung-Kun Chang et al.
ONCOLOGY RESEARCH (2020)
Cervical cancer: Epidemiology, risk factors and screening
Shaokai Zhang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2020)
Silibinin ameliorates amylin-induced pancreatic -cell apoptosis partly via upregulation of GLP-1R/PKA pathway
Jing Yang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Cold atmospheric plasma and silymarin nanoemulsion synergistically inhibits human melanoma tumorigenesis via targeting HGF/c-MET downstream pathway
Manish Adhikari et al.
CELL COMMUNICATION AND SIGNALING (2019)
Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR-125b/miR-182 in human breast cancer cells
Samaneh Hossainzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review
Vahid Soleimani et al.
PHYTOTHERAPY RESEARCH (2019)
Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma
Gayathri Heenatigala Palliyage et al.
AAPS PHARMSCITECH (2019)
Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial
Hedyieh Karbasforooshan et al.
PHYTOTHERAPY RESEARCH (2019)
The Mediterranean Diet and Breast Cancer: A Personalised Approach
Amani Al Shaikh et al.
HEALTHCARE (2019)
Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line
Seyede Elmira Yazdi Rouholamini et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Silymarin nanoemulsion against human hepatocellular carcinoma: development and optimization
Usama Ahmad et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
Devesh Tewari et al.
PHARMACOLOGICAL RESEARCH (2018)
Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Mehdi Koushki et al.
CLINICAL THERAPEUTICS (2018)
Silymarin nanoformulation as potential anticancer agent in experimental Ehrlich ascites carcinoma-bearing animals
Mohamed El-Far et al.
NANOMEDICINE (2018)
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
Hao Huang
SENSORS (2018)
Polyphenols in Food: Cancer Prevention and Apoptosis Induction
Ashita Sharma et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Resveratrol: A miraculous natural compound for diseases treatment
Mehdi Koushki et al.
FOOD SCIENCE & NUTRITION (2018)
Synergistic Interaction of Rutin and Silibinin on Human Colon Cancer Cell Line
Sana Nafees et al.
ARCHIVES OF MEDICAL RESEARCH (2018)
Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells
Maryam Mombeini et al.
MEDICINA-LITHUANIA (2018)
Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action
Thazin Nwe Aung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Calcitriol Reverses Induced Expression of Efflux Proteins and Potentiates Cytotoxic Activity of Gemcitabine in Capan-2 Pancreatic Cancer Cells
Hamed Gilzad-Kohan et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2017)
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
Alessandro Federico et al.
MOLECULES (2017)
Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism
Michal Bijak
MOLECULES (2017)
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
Valentina Belli et al.
Oncotarget (2017)
Cervical cancer control in HIV-infected women: Past, present and future
Rahel G. Ghebre et al.
GYNECOLOGIC ONCOLOGY REPORTS (2017)
Inhibition of Wnt Signaling by Silymarin in Human Colorectal Cancer Cells
Hyun Ji Eo et al.
BIOMOLECULES & THERAPEUTICS (2016)
Curcumin Sensitizes Silymarin to Exert Synergistic Anticancer Activity in Colon Cancer Cells
Amanda Montgomery et al.
JOURNAL OF CANCER (2016)
Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy
Komal Raina et al.
JOURNAL OF BIOMEDICAL RESEARCH (2016)
Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells
Wan Feng et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells
Vandanajay Bhatia et al.
CANCER LETTERS (2015)
Multistage vector delivery of sulindac and silymarin for prevention of colon cancer
Maria Principia Scavo et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells
Hyun Ji Eo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo
Gang Yang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Herbal product silibinin-induced programmed cell death is enhanced by metformin in cervical cancer cells at the dose without influence on nonmalignant cells
Wen-Shiung Liou et al.
JOURNAL OF APPLIED BIOMEDICINE (2015)
Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model
I. E. Leon et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2015)
Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells
Cheng-Chia Tsai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
Surendra K. Shukla et al.
ONCOTARGET (2015)
Improved dissolution and bioavailability of silymarin delivered by a solid dispersion prepared using supercritical fluids
Gang Yang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Silibinin Inhibits Proliferation, Induces Apoptosis and Causes Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells Via STAT3 Pathway Inhibition
Yi-Xin Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Breast Cancer: Major Risk Factors and Recent Developments in Treatment
Wafa Majeed et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Silymarin Inhibits Cytokine-Stimulated Pancreatic Beta Cells by Blocking the ERK1/2 Pathway
Eun Jeong Kim et al.
BIOMOLECULES & THERAPEUTICS (2014)
Silymarin in Liposomes and Ethosomes: Pharmacokinetics and Tissue Distribution in Free-Moving Rats by High-Performance Liquid Chromatography-Tandem Mass Spectrometry
Li-Wen Chang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2014)
Silymarin Encapsulated Poly(D,L-lactic-co-glycolic acid) Nanoparticles: A Prospective Candidate for Prostate Cancer Therapy
K. S. Snima et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Enhanced cytotoxicity and apoptosis-induced anticancer effect of silibinin-loaded nanoparticles in oral carcinoma (KB) cells
M. Gohulkumar et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2014)
Response of Breast Cancer Cells and Cancer Stem Cells to Metformin and Hyperthermia Alone or Combined
Hyemi Lee et al.
PLOS ONE (2014)
Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals
Sushil Kumar et al.
ONCOTARGET (2014)
Hepatoprotective effect of silymarin
Nancy Vargas-Mendoza et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Beyond Mammography: New Frontiers in Breast Cancer Screening
Jennifer S. Drukteinis et al.
AMERICAN JOURNAL OF MEDICINE (2013)
Roles of Plant Extracts and Constituents in Cervical Cancer Therapy
Lakhan Kma
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
In vitro and in vivo anticancer efficacy of silibinin against human pancreatic cancer BxPC-3 and PANC-1 cells
Dhanya Nambiar et al.
CANCER LETTERS (2013)
Silymarin loaded liposomes for hepatic targeting: In vitro evaluation and HepG2 drug uptake
Mohammed Elmowafy et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Plants and cervical cancer: an overview
Su-Juan Wang et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Gastric Cancer: Overview
Pelayo Correa
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2013)
Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS
Pengfei Xu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Effect of silibinin in human colorectal cancer cells: Targeting the activation of NF-κB signaling
Komal Raina et al.
MOLECULAR CARCINOGENESIS (2013)
Silibinin Triggers Apoptosis and Cell-Cycle Arrest of SGC7901 Cells
Yuanxin Zhang et al.
PHYTOTHERAPY RESEARCH (2013)
Epigenetic effects of the natural flavonolignan silibinin on colon adenocarcinoma cells and their derived metastatic cells
Henriette Kauntz et al.
ONCOLOGY LETTERS (2013)
Curcumin Inhibits TGF-β1-Induced MMP-9 and Invasion through ERK and Smad Signaling in Breast Cancer MDA-MB-231 Cells
Na Mo et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells
Hina Kausar et al.
CANCER LETTERS (2012)
Colon cancer chemopreventive efficacy of silibinin through perturbation of xenobiotic metabolizing enzymes in experimental rats
Nagarajan Sangeetha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Silibinin, a natural flavonoid, modulates the early expression of chemoprevention biomarkers in a preclinical model of colon carcinogenesis
Henriette Kauntz et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Silibinin Inhibits the Invasion of IL-6-Stimulated Colon Cancer Cells via Selective JNK/AP-1/MMP-2 Modulation in Vitro
Chiu-Mei Lin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
Kiyohito Kato et al.
MOLECULAR CANCER THERAPEUTICS (2012)
MicroRNAs in pancreatic cancer metabolism
Pankaj K. Singh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Absorption and metabolism of milk thistle flavanolignans in humans
Luca Calani et al.
PHYTOMEDICINE (2012)
Silymarin Inhibits Cervical Cancer Cell Through an Increase of Phosphatase and Tensin Homolog
Hann-Chin Yu et al.
PHYTOTHERAPY RESEARCH (2012)
Phytochemicals Attenuating Aberrant Activation of β-Catenin in Cancer Cells
Dan Wang et al.
PLOS ONE (2012)
The treatment of melasma by silymarin cream
Tagreed Altaei
BMC DERMATOLOGY (2012)
In vitro antitumor activity of silybin nanosuspension in PC-3 cells
Dandan Zheng et al.
CANCER LETTERS (2011)
Silymarin as a potential novel addition to the limited anti-vitiligo weaponry: an untested hypothesis
A. Feily et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
Silibinin Causes Apoptosis and Cell Cycle Arrest in Some Human Pancreatic Cancer Cells
Yakun Ge et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Flavonoids: Potential Wnt/beta-catenin signaling modulators in cancer
Nathalia G. Amado et al.
LIFE SCIENCES (2011)
Silymarin Targets β-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells
Mudit Vaid et al.
PLOS ONE (2011)
Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles
Jiang-nan Yu et al.
ACTA PHARMACOLOGICA SINICA (2010)
Chemoprevention of Intestinal Tumorigenesis in APCmin/+ Mice by Silibinin
Subapriya Rajamanickam et al.
CANCER RESEARCH (2010)
Inhibitory Effect of Silibinin against Azoxymethane-Induced Colon Tumorigenesis in A/J Mice
Kameswaran Ravichandran et al.
CLINICAL CANCER RESEARCH (2010)
Oral supplementation of silibinin prevents colon carcinogenesis in a long term preclinical model
Nagarajan Sangeetha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Silibinin ameliorates oxidative stress induced aberrant crypt foci and lipid peroxidation in 1, 2 dimethylhydrazine induced rat colon cancer
Nagarajan Sangeetha et al.
INVESTIGATIONAL NEW DRUGS (2010)
Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention
Wu-Yang Huang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
Silibinin Exerts Sustained Growth Suppressive Effect against Human Colon Carcinoma SW480 Xenograft by Targeting Multiple Signaling Molecules
Balaiya Velmurugan et al.
PHARMACEUTICAL RESEARCH (2010)
Silibinin Suppresses Growth of Human Colorectal Carcinoma SW480 Cells in Culture and Xenograft through Down-regulation of β-Catenin-Dependent Signaling
Manjinder Kaur et al.
NEOPLASIA (2010)
Predictors of quality of life in breast cancer patients under chemotherapy
A Safaee et al.
INDIAN JOURNAL OF CANCER (2009)
Role of tacrolimus (FK506) 0.1% ointment WW in vitiligo in children and imperatives of combine therapy with Trioxsalen and Silymarin suspension in progressive vitiligo
V. N. Sehgal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Silibinin Suppresses TNF-α-Induced MMP-9 Expression in Gastric Cancer Cells through Inhibition of the MAPK Pathway
Sangmin Kim et al.
MOLECULES (2009)
Silibinin inhibits hypoxia-inducible factor-1α and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy
P. Garcia-Maceira et al.
ONCOGENE (2009)
Inhibition of Azoxymethane-Induced Colonic Aberrant Crypt Foci Formation by Silibinin in Male Fisher 344 Rats
Balaiya Velmurugan et al.
CANCER PREVENTION RESEARCH (2008)
Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation
Enzo Berardesca et al.
Journal of Cosmetic Dermatology (2008)
An updated systematic review with meta-analysis for the clinical evidence of silymarin
Reinhard Saller et al.
FORSCHENDE KOMPLEMENTARMEDIZIN (2008)
Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application
Jhy-Wen Wu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Silybin is metabolized by cytochrome P4502C8 in vitro
Petra Jancova et al.
DRUG METABOLISM AND DISPOSITION (2007)
TGF-β signaling alterations and susceptibility to colorectal cancer
Yanfei Xu et al.
HUMAN MOLECULAR GENETICS (2007)
Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance
Mohamed S. El-Samaligy et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Cellular aspects of photocarcinogenesis
C Nishigori
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2006)
Enhancement of mammary carcinogenesis in two rodent models by silymarin dietary supplements
Barbara Malewicz et al.
CARCINOGENESIS (2006)
Silymarin augments human cervical cancer HeLa cell apoptosis via P38/JNK MAPK pathways in serum-free medium
Q Huang et al.
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2005)
Spices as influencers of body metabolism: an overview of three decades of research
K Srinivasan
FOOD RESEARCH INTERNATIONAL (2005)
Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: Implication of c-Jun NH2-terminal kinase and Janus kinase/signal transducer and activator of transcription pathways
T Matsuda et al.
ENDOCRINOLOGY (2005)
Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents
M Takahashi et al.
CANCER SCIENCE (2004)
Application of liquid chromatography-electrospray ionization-ion trap mass spectrometry to investigate the metabolism of silibinin in human liver microsomes
C Gunaratna et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis
RP Singh et al.
CARCINOGENESIS (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
APC, signal transduction and genetic instability in colorectal cancer
R Fodde et al.
NATURE REVIEWS CANCER (2001)
Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin
J Zhao et al.
CARCINOGENESIS (2000)
Share Paper
